Literature DB >> 2648386

Phosphorylation and disassembly of intermediate filaments in mitotic cells.

Y H Chou1, E Rosevear, R D Goldman.   

Abstract

As baby hamster kidney (BHK-21) cells enter mitosis, networks of intermediate filaments (IFs) are transformed into cytoplasmic aggregates of protofilaments. Coincident with this morphological change, the phosphate content of vimentin increases from 0.3 mol of Pi per mol of protein in interphase to 1.9 mol of Pi per mol of protein in mitosis. A similar increase in phosphate content is observed with desmin, from 0.5 mol of Pi per mol of protein to 1.5 mol of Pi per mol of protein. Fractionation of mitotic cell lysates by hydroxylapatite column chromatography reveals the presence of two IF protein kinase activities, designated as IF protein kinase I and IF protein kinase II. Comparison of two-dimensional 32P-labeled phosphopeptide maps of vimentin and desmin phosphorylated in vivo in mitosis, and in vitro using partially purified kinase fractions, reveals extensive similarity in the two sets of phosphorylation sites. Phosphorylation of in vitro polymerized IFs by IF protein kinase II induces complete disassembly as determined by negative-stain electron microscopy. The results support the idea that the disassembly of IFs in mitosis is regulated by the phosphorylation of its subunit proteins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2648386      PMCID: PMC286809          DOI: 10.1073/pnas.86.6.1885

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  In vitro assembly of intermediate filaments from baby hamster kidney (BHK-21) cells.

Authors:  R V Zackroff; R D Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Intermediate filaments of the vimentin-type and the cytokeratin-type are distributed differently during mitosis.

Authors:  J E Aubin; M Osborn; W W Franke; K Weber
Journal:  Exp Cell Res       Date:  1980-09       Impact factor: 3.905

4.  Reorganization of arrays of prekeratin filaments during mitosis. Immunofluorescence microscopy with multiclonal and monoclonal prekeratin antibodies.

Authors:  B Horwitz; H Kupfer; Z Eshhar; B Geiger
Journal:  Exp Cell Res       Date:  1981-08       Impact factor: 3.905

5.  Quantification of Coomassie Blue stained proteins in polyacrylamide gels based on analyses of eluted dye.

Authors:  C Fenner; R R Traut; D T Mason; J Wikman-Coffelt
Journal:  Anal Biochem       Date:  1975-02       Impact factor: 3.365

6.  The nuclear envelope lamina is reversibly depolymerized during mitosis.

Authors:  L Gerace; G Blobel
Journal:  Cell       Date:  1980-01       Impact factor: 41.582

7.  The intermediate-filament proteins vimentin and desmin are phosphorylated in specific domains.

Authors:  R M Evans
Journal:  Eur J Cell Biol       Date:  1988-04       Impact factor: 4.492

8.  The synthesis and distribution of desmin and vimentin during myogenesis in vitro.

Authors:  D L Gard; E Lazarides
Journal:  Cell       Date:  1980-01       Impact factor: 41.582

9.  Phosphorylation of intermediate filament proteins by cAMP-dependent protein kinases.

Authors:  C M O'Connor; D L Gard; E Lazarides
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

10.  Biochemical and immunological analysis of rapidly purified 10-nm filaments from baby hamster kidney (BHK-21) cells.

Authors:  J M Starger; W E Brown; A E Goldman; R D Goldman
Journal:  J Cell Biol       Date:  1978-07       Impact factor: 10.539

View more
  42 in total

1.  Nestin promotes the phosphorylation-dependent disassembly of vimentin intermediate filaments during mitosis.

Authors:  Ying-Hao Chou; Satya Khuon; Harald Herrmann; Robert D Goldman
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

2.  Cloning, characterization, and expression of a 200-kilodalton diagnostic antigen of Babesia bigemina.

Authors:  N Tebele; R A Skilton; J Katende; C W Wells; V Nene; T McElwain; S P Morzaria; A J Musoke
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Cell cycle-dependent changes in the organization of an intermediate filament-associated protein: correlation with phosphorylation by p34cdc2.

Authors:  O Skalli; Y H Chou; R D Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

4.  Cytoskeletal integrity in interphase cells requires protein phosphatase activity.

Authors:  J E Eriksson; D L Brautigan; R Vallee; J Olmsted; H Fujiki; R D Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

Review 5.  Intermediate Filaments Play a Pivotal Role in Regulating Cell Architecture and Function.

Authors:  Jason Lowery; Edward R Kuczmarski; Harald Herrmann; Robert D Goldman
Journal:  J Biol Chem       Date:  2015-05-08       Impact factor: 5.157

Review 6.  Intermediate filaments in smooth muscle.

Authors:  Dale D Tang
Journal:  Am J Physiol Cell Physiol       Date:  2008-02-06       Impact factor: 4.249

Review 7.  Introducing intermediate filaments: from discovery to disease.

Authors:  John E Eriksson; Thomas Dechat; Boris Grin; Brian Helfand; Melissa Mendez; Hanna-Mari Pallari; Robert D Goldman
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

8.  Effects of phosphorylation of the neurofilament L protein on filamentous structures.

Authors:  S Hisanaga; Y Gonda; M Inagaki; A Ikai; N Hirokawa
Journal:  Cell Regul       Date:  1990-01

Review 9.  Implications of intermediate filament protein phosphorylation.

Authors:  N O Ku; J Liao; C F Chou; M B Omary
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

10.  Suppression of glial tumor growth by expression of glial fibrillary acidic protein.

Authors:  M Toda; M Miura; H Asou; I Sugiyama; T Kawase; K Uyemura
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.